BCL2 and central nervous system cancer: Upregulated expression of CRNDE induces EGFR (epidermal growth factor receptor) activation, resulting in apoptosis inhibition through an increased Bcl2 (B-cell CLL/lymphoma 2)/Bax (BCL2-associated X) ratio and an association with poor survival in glioma patients (59).